|
| |
Xanthine
Mode of action
relaxes bronchial smooth muscle but mode of action not completely understood
probably involves competitive inhibition of adenosine receptors
inhibition of phosphodiesterase is negligible at therapeutic concentrations
improves diaphragmatic contraction
increases rate and force of cardiac contraction
increases rate of urine production
Pharmacokinetics
Administration: PO: absorption usually rapid and complete. Theophylline
is relatively insoluble. Aminophylline is a mixture of theophylline with
ethylenediamine which is sufficiently soluble for IV use. Give by slow IV
injection/infusion
Distribution: widely distributed
Elimination: 90% metabolized by liver. There is evidence that the process
is saturable at therapeutic doses. T1/2 8h but there is marked
variation. Prolonged in patients with severe cardiovascular disease and in
cirrhosis. Obesity and prematurity associated with reduced rates of elimination
whereas tobacco or cannabis enhances clearance by inducing hepatic enzymes
Clinical uses
chronic and acute asthma
COPD
Adverse effects
nausea and diarrhoea at high therapeutic levels
cardiac arrhythmias and fits when plasma concentration exceeds recommended
range
Drug interactions
Reduced rates of theophylline elimination due to enzyme inhibition by:
erythromycin, ciprofloxacin, allopurinol, oral contraceptives
Enhanced elimination due to enzyme induction by:
carbamazepine, phenobarbitone, phenytoin
Poisoning
Click here for details
© Charles Gomersall December 1999
|